A cost-effectiveness analysis of positron emission tomography-computed tomography surveillance versus up-front neck dissection for management of the neck for N2 disease after chemoradiotherapy

Laryngoscope. 2012 Feb;122(2):311-4. doi: 10.1002/lary.22464. Epub 2012 Jan 17.

Abstract

Objectives/hypothesis: To study the cost effectiveness of positron emission tomography-computerized tomography (PET-CT) scanning in the management of the neck after chemoradiotherapy (CRT).

Study design: Cost effectiveness and decision analysis model.

Methods: A cost-effectiveness analysis comparing up-front neck dissection to serial PET-CT imaging in a hypothetical clinical scenario of debate. A patient with an oropharygeal cancer with pretreatment N2 disease having a complete response was considered. Standardized costs were obtained using national databases. A literature review in PubMed was performed to obtain information on incidence, probabilities, and range for various clinical events in the algorithm.

Results: PET-CT strategy costs an average of $14,492 per patient. Neck dissection had a 0.6% greater efficacy in controlling neck disease with a $22,433 incremental cost.

Conclusions: Our results strongly support the use of PET-CT imaging as the more cost-effective strategy for surveillance of neck after completion of definitive CRT compared to up-front neck dissection.

Publication types

  • Comparative Study

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / diagnostic imaging*
  • Carcinoma, Squamous Cell / secondary
  • Carcinoma, Squamous Cell / therapy
  • Cost-Benefit Analysis
  • Elective Surgical Procedures / economics*
  • Elective Surgical Procedures / methods
  • Follow-Up Studies
  • Head and Neck Neoplasms / diagnostic imaging*
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / therapy
  • Humans
  • Lymphatic Metastasis / diagnostic imaging
  • Multimodal Imaging / economics*
  • Neck Dissection / economics
  • Neck Dissection / methods*
  • Neoplasm Staging
  • Positron-Emission Tomography*
  • Radiotherapy, Adjuvant
  • Reproducibility of Results
  • Retrospective Studies
  • Time Factors
  • Tomography, X-Ray Computed*

Substances

  • Antineoplastic Agents